148 related articles for article (PubMed ID: 6597118)
1. Reversal of multidrug resistance by non-antitumor anthracycline analogs.
Inaba M; Nagashima K; Sakurai Y; Fukui M; Yanagi Y
Gan; 1984 Dec; 75(12):1049-52. PubMed ID: 6597118
[TBL] [Abstract][Full Text] [Related]
2. Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists.
Kessel D; Wilberding C
Cancer Res; 1985 Apr; 45(4):1687-91. PubMed ID: 3919944
[TBL] [Abstract][Full Text] [Related]
3. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
Tsuruo T
Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181
[TBL] [Abstract][Full Text] [Related]
4. Biochemical mechanism for resistance to anthracycline antibiotics.
Inaba M
Prog Clin Biol Res; 1986; 223():35-44. PubMed ID: 3468518
[No Abstract] [Full Text] [Related]
5. Non-antitumor vinca alkaloids reverse multidrug resistance in P388 leukemia cells in vitro.
Inaba M; Nagashima K
Jpn J Cancer Res; 1986 Feb; 77(2):197-204. PubMed ID: 3082832
[TBL] [Abstract][Full Text] [Related]
6. Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists.
Klohs WD; Steinkampf RW; Havlick MJ; Jackson RC
Cancer Res; 1986 Sep; 46(9):4352-6. PubMed ID: 3460695
[TBL] [Abstract][Full Text] [Related]
7. Acquired vs innate multidrug resistance and the effect of calcium channel blockers.
Tsuruo T
Prog Clin Biol Res; 1986; 223():203-16. PubMed ID: 3468516
[TBL] [Abstract][Full Text] [Related]
8. Effects of tunicamycin on anthracycline resistance in P388 murine leukemia cells.
Chou TH; Kessel D
Biochem Pharmacol; 1981 Nov; 30(22):3134-6. PubMed ID: 6950722
[No Abstract] [Full Text] [Related]
9. Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics.
Tsuruo T
Cancer Treat Rep; 1983 Oct; 67(10):889-94. PubMed ID: 6354436
[TBL] [Abstract][Full Text] [Related]
10. [Studies on the mechanism of multidrug resistance].
Inaba M
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):807-14. PubMed ID: 3471182
[TBL] [Abstract][Full Text] [Related]
11. Mode of action of calcium antagonists which alter anthracycline resistance.
Kessel D; Wilberding C
Biochem Pharmacol; 1984 Apr; 33(7):1157-60. PubMed ID: 6585204
[No Abstract] [Full Text] [Related]
12. Interactions between calcium antagonists, calcium fluxes and anthracycline transport.
Kessel D; Wilberding C
Cancer Lett; 1984 Nov; 25(1):97-101. PubMed ID: 6097354
[TBL] [Abstract][Full Text] [Related]
13. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
Tsuruo T; Iida H; Nojiri M; Tsukagoshi S; Sakurai Y
Cancer Res; 1983 Jun; 43(6):2905-10. PubMed ID: 6850602
[TBL] [Abstract][Full Text] [Related]
14. Cellular pharmacology of anthracycline resistance and its circumvention.
Tapiero H; Fourcade A; Munck JN; Zwingelstein G; Lampidis TJ
Drugs Exp Clin Res; 1986; 12(1-3):265-73. PubMed ID: 3460753
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia.
Tsuruo T; Oh-Hara T; Sudo Y; Naito M
Anticancer Res; 1993; 13(2):357-61. PubMed ID: 8517647
[TBL] [Abstract][Full Text] [Related]
16. Overcoming drug resistance in cancer cells with synthetic isoprenoids.
Yamaguchi T; Nakagawa M; Shiraishi N; Yoshida T; Kiyosue T; Arita M; Akiyama S; Kuwano M
J Natl Cancer Inst; 1986 May; 76(5):947-53. PubMed ID: 3457980
[TBL] [Abstract][Full Text] [Related]
17. Phosphorus-containing metabolites in anthracycline-resistant murine leukemia P388 cells.
Shiryaeva OA; Semenova NA; Sibeldina LA; Goncharova SA; Konovalova NP
Neoplasma; 1992; 39(4):229-32. PubMed ID: 1436233
[TBL] [Abstract][Full Text] [Related]
18. Cellular accumulation and disposition of aclacinomycin A.
Egorin MJ; Clawson RE; Ross LA; Schlossberger NM; Bachur NR
Cancer Res; 1979 Nov; 39(11):4396-400. PubMed ID: 498071
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of antitumor agents by calcium channel blockers with special reference to cross-resistance patterns.
Tsuruo T; Kawabata H; Nagumo N; Iida H; Kitatani Y; Tsukagoshi S; Sakurai Y
Cancer Chemother Pharmacol; 1985; 15(1):16-9. PubMed ID: 4006044
[TBL] [Abstract][Full Text] [Related]
20. Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors.
Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
Cancer Res; 1982 Nov; 42(11):4730-3. PubMed ID: 7127307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
